Federal Register / Vol. 71, No. 169 / Thursday, August 31, 2006 / Notices 51833 

electronically each every fiscal year at 

http://www.grants.gov. 

Joan E. Ohl, 

Commissioner, Administration on Children, 

Youth and Families. 

[FR Doc. 06–7364 Filed 8–30–06; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Anti-Infective Drugs Advisory 

Committee Meeting; Amendment of 

Notice 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

amendment to the notice of a meeting of 

the Anti-Infective Drugs Advisory 

Committee. This meeting was 

announced in the Federal Register of 

July 25, 2006 (71 FR 42096). The 

amendment is being made to reflect a 

change in the Date and Time and 

Agenda portions of the document. The 

meeting scheduled for September 11, 

2006, has been cancelled. There are no 

other changes. 

FOR FURTHER INFORMATION CONTACT: 

Sohail Mosaddegh, Center for Drug 

Evaluation and Research (HFD–21), 

Food and Drug Administration, 5600 

Fishers Lane (for express delivery, 5630 

Fishers Lane, rm. 1093), Rockville, MD 

20857, 301–827–7001, FAX: 301–827–

6776, e-mail: 

sohail.mosaddegh@fda.hhs.gov, or FDA 

Advisory Committee Information Line, 

1–800–741–8138 (301–443–0572 in the 

Washington DC area), code 3014512530. 

Please call the Information Line for upto-date information on this meeting. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of July 25, 2006 (71 FR 

42096), FDA announced that a meeting 

of the Anti-Infective Drugs would be 

held on September 11 and 12, 2006. On 

page 42096, in the second column, the 

Date and Time portion of the meeting is 

amended to read as follows: 

Date and Time: The meeting will held 

on September 12, 2006, from 8 a.m. to 

5 p.m. 

On page 42096, third column, the 

Agenda portion of the meeting is 

amended to read as follows: 

Agenda: On September 12, 2006, the 

committee will discuss supplemental 

new drug application (sNDA) 21–158/S–

006, FACTIVE (gemifloxacin mesylate) 

Tablets, submitted by Oscient 

Pharmaceuticals Corp., for the proposed 

treatment of acute baterial sinusitis. 

This notice is issued under the 

Federal Advisory Committee Act (5 

U.S.C. app. 2) and 21 CFR part 14, 

relating to advisory committees. 

Dated: August 25, 2006. 

Randall W. Lutter, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. 06–7310 Filed 8–30–06; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Data Collection; Comment 

Request; California Health Interview 

Survey 2007 

SUMMARY: In compliance with the 

requirement of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995 

for opportunity for public comment on 

proposed data collection projects, 

National Cancer Institute (NCI), the 

National Institute of Health (NIH) will 

publish periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

The first California Health Interview 

Survey (CHIS) Cancer Control Module 

(CCM) took place in 2001 (2000 CHIS 

CCM, OMB No. 0925–0478, Federal 

Register, May 8, 2000, Vol. 65, No. 89, 

p. 26620). The second survey took place 

in 2003 (2003 CHIS CCM, OMB No. 

0925–0518, Federal Register, October 3, 

2002, Volume 67, No. 192, pp. 62067–

62068) and the third in 2005 (2005 CHIS 

CCM, OMB No. 0925–0000, Federal 

Register, Vol. 69, No. 150, Aug. 5, 2004, 

pp. 47450–47451, and Federal Register, 

Vol. 70, No. 1, Jan. 3, 2005, pp. 93–94). 

Proposed Collection 

Title: California Health Interview 

Survey (CHIS) 2007 Cancer Control 

Module (CCM). Type of Information 

Collection Request: New. Need and Use 

of Information Collection: The NCI has 

sponsored three Cancer Control 

Modules in the California Health 

Interview Survey (CHIS), and will be 

sponsoring a fourth to be administered 

in 2007. 

The CHIS is a telephone survey 

designed to provide population-based, 

standardized health-related data to 

assess California’s progress in meeting 

Healthy People 2010 objectives for the 

nation and the state. The CHIS sample 

is designed to provide statistically 

reliable estimates statewide, for 

California counties, and for California’s 

ethnically and racially diverse 

population. Initiated by the UCLA 

Center for Health Policy Research, the 

California Department of Health 

Services, and the California Public 

Health Institute, the survey is funded by 

a number of public and private sources. 

It was first administered in 2001 to 

55,428 adults and subsequently in 2003 

and 2005 to 42,043 and 43,020 adults 

respectively. These adults are a 

representative sample of California’s 

non-institutionalized population living 

in households. 

CHIS 2007, the fourth bi-annual 

survey, is planned for administration to 

55,000 adult Californians. The cancer 

control module, which is similar to that 

administered in CHIS 2001, CHIS 2003, 

and CHIS 2005, will allow NCI to 

examine trends in breast cancer 

screening and diagnosis, as well as to 

study other cancer-related topics such 

as diet, physical activity, and obesity. 

Because California is the most 

populous and the most racially and 

ethnically diverse state in the nation, 

the CHIS 2007 sample will yield 

adequate numbers of respondents in key 

ethnic and racial groups, including 

African Americans, Latinos, Asians, and 

American Indian/Alaska Natives. The 

Latino group will include large numbers 

of respondents in the Mexican, Central 

American, South American, and other 

Latino subgroups; the Asian group will 

include large numbers of respondents in 

the Chinese, Filipino, Japanese, 

Vietnamese, and Korean subgroups. NCI 

will compare the CHIS and National 

Health Interview Survey (NHIS) data in 

order to conduct comparative analyses 

and better estimate cancer risk factors 

and screening among racial/ethnic 

minority populations. The CHIS sample 

size also permits NCI to create estimates 

for ethnic subdomains of the 

population, for which NHIS has 

insufficient numbers for analysis. 

Frequency of Response: One-time. 

Affected public: Individuals or 

households. Types of Respondents: U.S. 

adults (persons 18 years of age and 

older). 

The annual reporting burden is as 

follows. 


erjones on PROD1PC72 with NOTICES